A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors
- DOI
- 10.1158/1078-0432.ccr-25-4374
- Published
- 2026-08-27
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-4374,
title = {A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors},
author = {Lillian L. Siu and Omid Hamid and Reva Schneider and Jordi Rodon Ahnert and Scott A. Laurie and Frank Stephen Hodi and Dong-Wan Kim and Myung-Ju Ahn and Gary Carlson and Hussein Assi and Hamza Khan and Patrick Hanafin and Emily Moore and Madhu Ramaswamy and Reza Mozaffari and Stefan Zajic and Arindam Dhar and Ivan Diaz Padilla and Noboru Yamamoto},
year = {2026},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-25-4374},
url = {https://doi.org/10.1158/1078-0432.ccr-25-4374}
}RIS
TY - JOUR TI - A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors AU - Lillian L. Siu AU - Omid Hamid AU - Reva Schneider AU - Jordi Rodon Ahnert AU - Scott A. Laurie AU - Frank Stephen Hodi AU - Dong-Wan Kim AU - Myung-Ju Ahn AU - Gary Carlson AU - Hussein Assi AU - Hamza Khan AU - Patrick Hanafin AU - Emily Moore AU - Madhu Ramaswamy AU - Reza Mozaffari AU - Stefan Zajic AU - Arindam Dhar AU - Ivan Diaz Padilla AU - Noboru Yamamoto PY - 2026 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-25-4374 UR - https://doi.org/10.1158/1078-0432.ccr-25-4374 ER -
APA
Siu, L. L., Hamid, O., Schneider, R., Ahnert, J. R., Laurie, S. A., Hodi, F. S., Kim, D., Ahn, M., Carlson, G., Assi, H., Khan, H., Hanafin, P., Moore, E., Ramaswamy, M., Mozaffari, R., Zajic, S., Dhar, A., Padilla, I. D., & Yamamoto, N. (2026). A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4374
Source records
- crossref · retrieved 2026-11-10T13:37:38.504Z